Global EMG Biosensors Market

EMG Biosensors Comprehensive Study by Type (Dry EEG, Semi Dry EEG, Wet EEG (Soft Gel-Based, Saline Solution)), Category (Externally (Stimulus)-Paced Mode (Synchronous BCI), Internally Paced Mode (Asynchronous BCI)), End Use (Hospitals, Specialty Clinics), Connection (Wired and Wireless Communications, Electrode Connection) Players and Region - Global Market Outlook to 2026

EMG Biosensors Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
EMG Biosensors Market Scope
Electroencephalography (EEG) systems use electric potentials on the surface of living tissue to track heart, muscle, and brain activity throughout time. The ionic current flow in the body can be used to detect nerve stimulation and muscle contractions. The creation of biosensors that assess a variety of biosignals produced by human bodies is a crucial for health monitoring. Wearable-type biosensors have garnered greater attention as an alternative to laboratory equipment in recent years, as the need for real-time monitoring of individuals' health status has grown. These biosensors have been integrated in smart watches, clothing, and accessories in order to gather diverse biosignals in real time. Although wearable biosensors connected to the human body may gather biosignals with ease, there are difficulties with dependability owing to data collecting noise.

The EMG Biosensors market study is segmented by Type (Dry EEG, Semi Dry EEG and Wet EEG (Soft Gel-Based, Saline Solution)) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global EMG Biosensors market throughout the predicted period.

NeuroSky (United States), Max-Planck-Gesellschaft (Germany), Ceribell Inc. (United States), Bitbrain Technologies (Spain), Compumedics Neuroscan (United States), Butler Technologies (Ireland), g.tec neurotechnology GmbH (Austria), TMSi (Netherlands), BIOPAC Systems Inc. (United States) and EB Neuro S.p.A. (Italy) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are iMotions (Denmark), PLUX Wireless Biosignals S.A. (Portugal), OpenBCI (United States), Multi Bio Sensors Inc. (United States), Biometrics Ltd. (United States) and Delsys Incorporated (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AMA Research has segmented the market of Global EMG Biosensors market by Type, Application and Region.

On the basis of geography, the market of EMG Biosensors has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Leaders and their expansionary development strategies
On 9th June, 2019 – Blue Snail Medical & Biosensors International Acquired NVT AG. The Deal Combines NVT’s Expertise Across Innovative Transcatheter Aortic Valve Implantation Technology, And Biosensors’ Solid Track Record in Interventional Cardiology with Blue Snail’s R&D Capabilities to Serve Wider Range of Patients.
On 26th May, 2020 - Philips Launched Next Generation Wearable Biosensor for Early Patient Deterioration Detection, Including Clinical Surveillance For COVID-19. The New Wireless Philips BX100 Wearable Biosensor Had Previously Received 510(k) Clearance from The US FDA And CE Mark.


Market Trend
  • Emergence of Advance EMG Biosensor Systems

Market Drivers
  • Prevalence of Infectious Diseases
  • High Investment in Healthcare R&D

Opportunities
  • Growing Healthcare Infrastructure Across Emerging Regions

Restraints
  • Lack of Skilled Professionals
  • Raw Material Price Fluctuation

Challenges
  • Fierce Competitive Pressure


Key Target Audience
Philips Biosensor BX100Manufactures, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

Report Objectives / Segmentation Covered

By Type
  • Dry EEG
  • Semi Dry EEG
  • Wet EEG (Soft Gel-Based, Saline Solution)
By Category
  • Externally (Stimulus)-Paced Mode (Synchronous BCI)
  • Internally Paced Mode (Asynchronous BCI)

By End Use
  • Hospitals
  • Specialty Clinics

By Connection
  • Wired and Wireless Communications
  • Electrode Connection

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Prevalence of Infectious Diseases
      • 3.2.2. High Investment in Healthcare R&D
    • 3.3. Market Challenges
      • 3.3.1. Fierce Competitive Pressure
    • 3.4. Market Trends
      • 3.4.1. Emergence of Advance EMG Biosensor Systems
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global EMG Biosensors, by Type, Category, End Use, Connection and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global EMG Biosensors (Value)
      • 5.2.1. Global EMG Biosensors by: Type (Value)
        • 5.2.1.1. Dry EEG
        • 5.2.1.2. Semi Dry EEG
        • 5.2.1.3. Wet EEG (Soft Gel-Based, Saline Solution)
      • 5.2.2. Global EMG Biosensors by: Category (Value)
        • 5.2.2.1. Externally (Stimulus)-Paced Mode (Synchronous BCI)
        • 5.2.2.2. Internally Paced Mode (Asynchronous BCI)
      • 5.2.3. Global EMG Biosensors by: End Use (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Specialty Clinics
      • 5.2.4. Global EMG Biosensors by: Connection (Value)
        • 5.2.4.1. Wired and Wireless Communications
        • 5.2.4.2. Electrode Connection
      • 5.2.5. Global EMG Biosensors Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. EMG Biosensors: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. NeuroSky (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Max-Planck-Gesellschaft (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Ceribell Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Bitbrain Technologies (Spain)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Compumedics Neuroscan (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Butler Technologies (Ireland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. G.tec neurotechnology GmbH (Austria)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. TMSi (Netherlands)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. BIOPAC Systems Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. EB Neuro S.p.A. (Italy)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global EMG Biosensors Sale, by Type, Category, End Use, Connection and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global EMG Biosensors (Value)
      • 7.2.1. Global EMG Biosensors by: Type (Value)
        • 7.2.1.1. Dry EEG
        • 7.2.1.2. Semi Dry EEG
        • 7.2.1.3. Wet EEG (Soft Gel-Based, Saline Solution)
      • 7.2.2. Global EMG Biosensors by: Category (Value)
        • 7.2.2.1. Externally (Stimulus)-Paced Mode (Synchronous BCI)
        • 7.2.2.2. Internally Paced Mode (Asynchronous BCI)
      • 7.2.3. Global EMG Biosensors by: End Use (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Specialty Clinics
      • 7.2.4. Global EMG Biosensors by: Connection (Value)
        • 7.2.4.1. Wired and Wireless Communications
        • 7.2.4.2. Electrode Connection
      • 7.2.5. Global EMG Biosensors Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. EMG Biosensors: by Type(USD Million)
  • Table 2. EMG Biosensors Dry EEG , by Region USD Million (2015-2020)
  • Table 3. EMG Biosensors Semi Dry EEG , by Region USD Million (2015-2020)
  • Table 4. EMG Biosensors Wet EEG (Soft Gel-Based, Saline Solution) , by Region USD Million (2015-2020)
  • Table 5. EMG Biosensors: by Category(USD Million)
  • Table 6. EMG Biosensors Externally (Stimulus)-Paced Mode (Synchronous BCI) , by Region USD Million (2015-2020)
  • Table 7. EMG Biosensors Internally Paced Mode (Asynchronous BCI) , by Region USD Million (2015-2020)
  • Table 8. EMG Biosensors: by End Use(USD Million)
  • Table 9. EMG Biosensors Hospitals , by Region USD Million (2015-2020)
  • Table 10. EMG Biosensors Specialty Clinics , by Region USD Million (2015-2020)
  • Table 11. EMG Biosensors: by Connection(USD Million)
  • Table 12. EMG Biosensors Wired and Wireless Communications , by Region USD Million (2015-2020)
  • Table 13. EMG Biosensors Electrode Connection , by Region USD Million (2015-2020)
  • Table 14. South America EMG Biosensors, by Country USD Million (2015-2020)
  • Table 15. South America EMG Biosensors, by Type USD Million (2015-2020)
  • Table 16. South America EMG Biosensors, by Category USD Million (2015-2020)
  • Table 17. South America EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 18. South America EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 19. Brazil EMG Biosensors, by Type USD Million (2015-2020)
  • Table 20. Brazil EMG Biosensors, by Category USD Million (2015-2020)
  • Table 21. Brazil EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 22. Brazil EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 23. Argentina EMG Biosensors, by Type USD Million (2015-2020)
  • Table 24. Argentina EMG Biosensors, by Category USD Million (2015-2020)
  • Table 25. Argentina EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 26. Argentina EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 27. Rest of South America EMG Biosensors, by Type USD Million (2015-2020)
  • Table 28. Rest of South America EMG Biosensors, by Category USD Million (2015-2020)
  • Table 29. Rest of South America EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 30. Rest of South America EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 31. Asia Pacific EMG Biosensors, by Country USD Million (2015-2020)
  • Table 32. Asia Pacific EMG Biosensors, by Type USD Million (2015-2020)
  • Table 33. Asia Pacific EMG Biosensors, by Category USD Million (2015-2020)
  • Table 34. Asia Pacific EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 35. Asia Pacific EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 36. China EMG Biosensors, by Type USD Million (2015-2020)
  • Table 37. China EMG Biosensors, by Category USD Million (2015-2020)
  • Table 38. China EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 39. China EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 40. Japan EMG Biosensors, by Type USD Million (2015-2020)
  • Table 41. Japan EMG Biosensors, by Category USD Million (2015-2020)
  • Table 42. Japan EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 43. Japan EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 44. India EMG Biosensors, by Type USD Million (2015-2020)
  • Table 45. India EMG Biosensors, by Category USD Million (2015-2020)
  • Table 46. India EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 47. India EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 48. South Korea EMG Biosensors, by Type USD Million (2015-2020)
  • Table 49. South Korea EMG Biosensors, by Category USD Million (2015-2020)
  • Table 50. South Korea EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 51. South Korea EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 52. Taiwan EMG Biosensors, by Type USD Million (2015-2020)
  • Table 53. Taiwan EMG Biosensors, by Category USD Million (2015-2020)
  • Table 54. Taiwan EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 55. Taiwan EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 56. Australia EMG Biosensors, by Type USD Million (2015-2020)
  • Table 57. Australia EMG Biosensors, by Category USD Million (2015-2020)
  • Table 58. Australia EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 59. Australia EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 60. Rest of Asia-Pacific EMG Biosensors, by Type USD Million (2015-2020)
  • Table 61. Rest of Asia-Pacific EMG Biosensors, by Category USD Million (2015-2020)
  • Table 62. Rest of Asia-Pacific EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 64. Europe EMG Biosensors, by Country USD Million (2015-2020)
  • Table 65. Europe EMG Biosensors, by Type USD Million (2015-2020)
  • Table 66. Europe EMG Biosensors, by Category USD Million (2015-2020)
  • Table 67. Europe EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 68. Europe EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 69. Germany EMG Biosensors, by Type USD Million (2015-2020)
  • Table 70. Germany EMG Biosensors, by Category USD Million (2015-2020)
  • Table 71. Germany EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 72. Germany EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 73. France EMG Biosensors, by Type USD Million (2015-2020)
  • Table 74. France EMG Biosensors, by Category USD Million (2015-2020)
  • Table 75. France EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 76. France EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 77. Italy EMG Biosensors, by Type USD Million (2015-2020)
  • Table 78. Italy EMG Biosensors, by Category USD Million (2015-2020)
  • Table 79. Italy EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 80. Italy EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 81. United Kingdom EMG Biosensors, by Type USD Million (2015-2020)
  • Table 82. United Kingdom EMG Biosensors, by Category USD Million (2015-2020)
  • Table 83. United Kingdom EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 84. United Kingdom EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 85. Netherlands EMG Biosensors, by Type USD Million (2015-2020)
  • Table 86. Netherlands EMG Biosensors, by Category USD Million (2015-2020)
  • Table 87. Netherlands EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 88. Netherlands EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 89. Rest of Europe EMG Biosensors, by Type USD Million (2015-2020)
  • Table 90. Rest of Europe EMG Biosensors, by Category USD Million (2015-2020)
  • Table 91. Rest of Europe EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 92. Rest of Europe EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 93. MEA EMG Biosensors, by Country USD Million (2015-2020)
  • Table 94. MEA EMG Biosensors, by Type USD Million (2015-2020)
  • Table 95. MEA EMG Biosensors, by Category USD Million (2015-2020)
  • Table 96. MEA EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 97. MEA EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 98. Middle East EMG Biosensors, by Type USD Million (2015-2020)
  • Table 99. Middle East EMG Biosensors, by Category USD Million (2015-2020)
  • Table 100. Middle East EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 101. Middle East EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 102. Africa EMG Biosensors, by Type USD Million (2015-2020)
  • Table 103. Africa EMG Biosensors, by Category USD Million (2015-2020)
  • Table 104. Africa EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 105. Africa EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 106. North America EMG Biosensors, by Country USD Million (2015-2020)
  • Table 107. North America EMG Biosensors, by Type USD Million (2015-2020)
  • Table 108. North America EMG Biosensors, by Category USD Million (2015-2020)
  • Table 109. North America EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 110. North America EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 111. United States EMG Biosensors, by Type USD Million (2015-2020)
  • Table 112. United States EMG Biosensors, by Category USD Million (2015-2020)
  • Table 113. United States EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 114. United States EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 115. Canada EMG Biosensors, by Type USD Million (2015-2020)
  • Table 116. Canada EMG Biosensors, by Category USD Million (2015-2020)
  • Table 117. Canada EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 118. Canada EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 119. Mexico EMG Biosensors, by Type USD Million (2015-2020)
  • Table 120. Mexico EMG Biosensors, by Category USD Million (2015-2020)
  • Table 121. Mexico EMG Biosensors, by End Use USD Million (2015-2020)
  • Table 122. Mexico EMG Biosensors, by Connection USD Million (2015-2020)
  • Table 123. Company Basic Information, Sales Area and Its Competitors
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. EMG Biosensors: by Type(USD Million)
  • Table 134. EMG Biosensors Dry EEG , by Region USD Million (2021-2026)
  • Table 135. EMG Biosensors Semi Dry EEG , by Region USD Million (2021-2026)
  • Table 136. EMG Biosensors Wet EEG (Soft Gel-Based, Saline Solution) , by Region USD Million (2021-2026)
  • Table 137. EMG Biosensors: by Category(USD Million)
  • Table 138. EMG Biosensors Externally (Stimulus)-Paced Mode (Synchronous BCI) , by Region USD Million (2021-2026)
  • Table 139. EMG Biosensors Internally Paced Mode (Asynchronous BCI) , by Region USD Million (2021-2026)
  • Table 140. EMG Biosensors: by End Use(USD Million)
  • Table 141. EMG Biosensors Hospitals , by Region USD Million (2021-2026)
  • Table 142. EMG Biosensors Specialty Clinics , by Region USD Million (2021-2026)
  • Table 143. EMG Biosensors: by Connection(USD Million)
  • Table 144. EMG Biosensors Wired and Wireless Communications , by Region USD Million (2021-2026)
  • Table 145. EMG Biosensors Electrode Connection , by Region USD Million (2021-2026)
  • Table 146. South America EMG Biosensors, by Country USD Million (2021-2026)
  • Table 147. South America EMG Biosensors, by Type USD Million (2021-2026)
  • Table 148. South America EMG Biosensors, by Category USD Million (2021-2026)
  • Table 149. South America EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 150. South America EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 151. Brazil EMG Biosensors, by Type USD Million (2021-2026)
  • Table 152. Brazil EMG Biosensors, by Category USD Million (2021-2026)
  • Table 153. Brazil EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 154. Brazil EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 155. Argentina EMG Biosensors, by Type USD Million (2021-2026)
  • Table 156. Argentina EMG Biosensors, by Category USD Million (2021-2026)
  • Table 157. Argentina EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 158. Argentina EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 159. Rest of South America EMG Biosensors, by Type USD Million (2021-2026)
  • Table 160. Rest of South America EMG Biosensors, by Category USD Million (2021-2026)
  • Table 161. Rest of South America EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 162. Rest of South America EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 163. Asia Pacific EMG Biosensors, by Country USD Million (2021-2026)
  • Table 164. Asia Pacific EMG Biosensors, by Type USD Million (2021-2026)
  • Table 165. Asia Pacific EMG Biosensors, by Category USD Million (2021-2026)
  • Table 166. Asia Pacific EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 167. Asia Pacific EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 168. China EMG Biosensors, by Type USD Million (2021-2026)
  • Table 169. China EMG Biosensors, by Category USD Million (2021-2026)
  • Table 170. China EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 171. China EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 172. Japan EMG Biosensors, by Type USD Million (2021-2026)
  • Table 173. Japan EMG Biosensors, by Category USD Million (2021-2026)
  • Table 174. Japan EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 175. Japan EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 176. India EMG Biosensors, by Type USD Million (2021-2026)
  • Table 177. India EMG Biosensors, by Category USD Million (2021-2026)
  • Table 178. India EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 179. India EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 180. South Korea EMG Biosensors, by Type USD Million (2021-2026)
  • Table 181. South Korea EMG Biosensors, by Category USD Million (2021-2026)
  • Table 182. South Korea EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 183. South Korea EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 184. Taiwan EMG Biosensors, by Type USD Million (2021-2026)
  • Table 185. Taiwan EMG Biosensors, by Category USD Million (2021-2026)
  • Table 186. Taiwan EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 187. Taiwan EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 188. Australia EMG Biosensors, by Type USD Million (2021-2026)
  • Table 189. Australia EMG Biosensors, by Category USD Million (2021-2026)
  • Table 190. Australia EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 191. Australia EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 192. Rest of Asia-Pacific EMG Biosensors, by Type USD Million (2021-2026)
  • Table 193. Rest of Asia-Pacific EMG Biosensors, by Category USD Million (2021-2026)
  • Table 194. Rest of Asia-Pacific EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 195. Rest of Asia-Pacific EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 196. Europe EMG Biosensors, by Country USD Million (2021-2026)
  • Table 197. Europe EMG Biosensors, by Type USD Million (2021-2026)
  • Table 198. Europe EMG Biosensors, by Category USD Million (2021-2026)
  • Table 199. Europe EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 200. Europe EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 201. Germany EMG Biosensors, by Type USD Million (2021-2026)
  • Table 202. Germany EMG Biosensors, by Category USD Million (2021-2026)
  • Table 203. Germany EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 204. Germany EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 205. France EMG Biosensors, by Type USD Million (2021-2026)
  • Table 206. France EMG Biosensors, by Category USD Million (2021-2026)
  • Table 207. France EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 208. France EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 209. Italy EMG Biosensors, by Type USD Million (2021-2026)
  • Table 210. Italy EMG Biosensors, by Category USD Million (2021-2026)
  • Table 211. Italy EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 212. Italy EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 213. United Kingdom EMG Biosensors, by Type USD Million (2021-2026)
  • Table 214. United Kingdom EMG Biosensors, by Category USD Million (2021-2026)
  • Table 215. United Kingdom EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 216. United Kingdom EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 217. Netherlands EMG Biosensors, by Type USD Million (2021-2026)
  • Table 218. Netherlands EMG Biosensors, by Category USD Million (2021-2026)
  • Table 219. Netherlands EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 220. Netherlands EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 221. Rest of Europe EMG Biosensors, by Type USD Million (2021-2026)
  • Table 222. Rest of Europe EMG Biosensors, by Category USD Million (2021-2026)
  • Table 223. Rest of Europe EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 224. Rest of Europe EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 225. MEA EMG Biosensors, by Country USD Million (2021-2026)
  • Table 226. MEA EMG Biosensors, by Type USD Million (2021-2026)
  • Table 227. MEA EMG Biosensors, by Category USD Million (2021-2026)
  • Table 228. MEA EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 229. MEA EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 230. Middle East EMG Biosensors, by Type USD Million (2021-2026)
  • Table 231. Middle East EMG Biosensors, by Category USD Million (2021-2026)
  • Table 232. Middle East EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 233. Middle East EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 234. Africa EMG Biosensors, by Type USD Million (2021-2026)
  • Table 235. Africa EMG Biosensors, by Category USD Million (2021-2026)
  • Table 236. Africa EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 237. Africa EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 238. North America EMG Biosensors, by Country USD Million (2021-2026)
  • Table 239. North America EMG Biosensors, by Type USD Million (2021-2026)
  • Table 240. North America EMG Biosensors, by Category USD Million (2021-2026)
  • Table 241. North America EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 242. North America EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 243. United States EMG Biosensors, by Type USD Million (2021-2026)
  • Table 244. United States EMG Biosensors, by Category USD Million (2021-2026)
  • Table 245. United States EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 246. United States EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 247. Canada EMG Biosensors, by Type USD Million (2021-2026)
  • Table 248. Canada EMG Biosensors, by Category USD Million (2021-2026)
  • Table 249. Canada EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 250. Canada EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 251. Mexico EMG Biosensors, by Type USD Million (2021-2026)
  • Table 252. Mexico EMG Biosensors, by Category USD Million (2021-2026)
  • Table 253. Mexico EMG Biosensors, by End Use USD Million (2021-2026)
  • Table 254. Mexico EMG Biosensors, by Connection USD Million (2021-2026)
  • Table 255. Research Programs/Design for This Report
  • Table 256. Key Data Information from Secondary Sources
  • Table 257. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global EMG Biosensors: by Type USD Million (2015-2020)
  • Figure 5. Global EMG Biosensors: by Category USD Million (2015-2020)
  • Figure 6. Global EMG Biosensors: by End Use USD Million (2015-2020)
  • Figure 7. Global EMG Biosensors: by Connection USD Million (2015-2020)
  • Figure 8. South America EMG Biosensors Share (%), by Country
  • Figure 9. Asia Pacific EMG Biosensors Share (%), by Country
  • Figure 10. Europe EMG Biosensors Share (%), by Country
  • Figure 11. MEA EMG Biosensors Share (%), by Country
  • Figure 12. North America EMG Biosensors Share (%), by Country
  • Figure 13. Global EMG Biosensors share by Players 2020 (%)
  • Figure 14. Global EMG Biosensors share by Players (Top 3) 2020(%)
  • Figure 15. Global EMG Biosensors share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. NeuroSky (United States) Revenue, Net Income and Gross profit
  • Figure 18. NeuroSky (United States) Revenue: by Geography 2020
  • Figure 19. Max-Planck-Gesellschaft (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Max-Planck-Gesellschaft (Germany) Revenue: by Geography 2020
  • Figure 21. Ceribell Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Ceribell Inc. (United States) Revenue: by Geography 2020
  • Figure 23. Bitbrain Technologies (Spain) Revenue, Net Income and Gross profit
  • Figure 24. Bitbrain Technologies (Spain) Revenue: by Geography 2020
  • Figure 25. Compumedics Neuroscan (United States) Revenue, Net Income and Gross profit
  • Figure 26. Compumedics Neuroscan (United States) Revenue: by Geography 2020
  • Figure 27. Butler Technologies (Ireland) Revenue, Net Income and Gross profit
  • Figure 28. Butler Technologies (Ireland) Revenue: by Geography 2020
  • Figure 29. G.tec neurotechnology GmbH (Austria) Revenue, Net Income and Gross profit
  • Figure 30. G.tec neurotechnology GmbH (Austria) Revenue: by Geography 2020
  • Figure 31. TMSi (Netherlands) Revenue, Net Income and Gross profit
  • Figure 32. TMSi (Netherlands) Revenue: by Geography 2020
  • Figure 33. BIOPAC Systems Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. BIOPAC Systems Inc. (United States) Revenue: by Geography 2020
  • Figure 35. EB Neuro S.p.A. (Italy) Revenue, Net Income and Gross profit
  • Figure 36. EB Neuro S.p.A. (Italy) Revenue: by Geography 2020
  • Figure 37. Global EMG Biosensors: by Type USD Million (2021-2026)
  • Figure 38. Global EMG Biosensors: by Category USD Million (2021-2026)
  • Figure 39. Global EMG Biosensors: by End Use USD Million (2021-2026)
  • Figure 40. Global EMG Biosensors: by Connection USD Million (2021-2026)
  • Figure 41. South America EMG Biosensors Share (%), by Country
  • Figure 42. Asia Pacific EMG Biosensors Share (%), by Country
  • Figure 43. Europe EMG Biosensors Share (%), by Country
  • Figure 44. MEA EMG Biosensors Share (%), by Country
  • Figure 45. North America EMG Biosensors Share (%), by Country
List of companies from research coverage that are profiled in the study
  • NeuroSky (United States)
  • Max-Planck-Gesellschaft (Germany)
  • Ceribell Inc. (United States)
  • Bitbrain Technologies (Spain)
  • Compumedics Neuroscan (United States)
  • Butler Technologies (Ireland)
  • g.tec neurotechnology GmbH (Austria)
  • TMSi (Netherlands)
  • BIOPAC Systems Inc. (United States)
  • EB Neuro S.p.A. (Italy)
Additional players considered in the study are as follows:
iMotions (Denmark) , PLUX Wireless Biosignals S.A. (Portugal) , OpenBCI (United States) , Multi Bio Sensors Inc. (United States) , Biometrics Ltd. (United States) , Delsys Incorporated (United States)
Select User Access Type

Key Highlights of Report


Aug 2021 207 Pages 90 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global EMG Biosensors Market Quantitative research analysis
Global EMG Biosensors Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2026.

Know More About Global EMG Biosensors Market Report?

Have a Query? Click Here

Other Related Reports

Security Radar Device Comprehensive Study by Type (Imaging Radar, Non-imaging Radar), Application (Automotive, Security and Surveillance, Industrial, Environment and Weather Monitoring, Traffic Monit...
$ 3650
Proximity as a services Comprehensive Study by Technology (Bluetooth, Wi-Fi, GPS, Others), Devices (Android, IoS, Computer, Other), End user (BFSI, Automotive industries, Hospitals, Infrastructural, ...
$ 3500
Mobile LiDAR Scanner Comprehensive Study by Type (Dual Head Laser System, Three Head Laser System, Multi Head Laser System), Application (Transportation (Highway, Expressways), Railway Infrastructure...
$ 3800
eye-tracking technology Comprehensive Study by Application (Assistive Communication, Human Behaviour & Research, Others), Tracking type (Remote tracking, Mobile tracking), End User (Automotive, Medic...
$ 3800
Long Distance Car Radars Comprehensive Study by Type (4D Imaging Radars, 3D Imaging Radars), Application (Rear Area, Front Area), Frequency (77GHz, 60GHz) Players and Region - Global Market Outlook t...
$ 3400
Longwave Infrared (LWIR) Technology Comprehensive Study by Application (Medical, Military, Others), Range (160 × 120, 320 × 240, 640 × 480, 1024 × 768, Others), Channel (Online,  E-Commerce,...
$ 3800